Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab Dose Optimization in Ulcerative Colitis
NCT04156984Phase 4Completed
- Start
- Apr 2021
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
A Phase 4 trial of golimumab in ulcerative colitis (UC). Started Apr 2021; status: completed.
02
Drugs
golimumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04156984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04156984.